NCT02991261View on ClinicalTrials.gov

Bioavailability Study of SPARC001 (Study 2) in Healthy Adult Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

February 6, 2017

Primary Completion Date

March 15, 2017

Study Completion Date

April 1, 2017

Conditions
Healthy
Interventions
DRUG

SPARC001 type I

Treatment type I

DRUG

SPARC001 type II

Treatment type II

DRUG

Reference001 type I

Hydrocodone-acetaminophen

DRUG

Reference001 type II

Hydrocodone Acetaminophen

Trial Locations (1)

07094

SPARC Site 01, Secaucus

All Listed Sponsors
lead

Sun Pharma Advanced Research Company Limited

INDUSTRY

NCT02991261 - Bioavailability Study of SPARC001 (Study 2) in Healthy Adult Volunteers | Biotech Hunter | Biotech Hunter